Vor Biopharma Management
Management criteria checks 3/4
Vor Biopharma's CEO is Robert Ang, appointed in Aug 2019, has a tenure of 4.75 years. total yearly compensation is $2.69M, comprised of 22.5% salary and 77.5% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth $925.40K. The average tenure of the management team and the board of directors is 3.6 years and 3.8 years respectively.
Key information
Robert Ang
Chief executive officer
US$2.7m
Total compensation
| CEO salary percentage | 22.5% |
| CEO tenure | 4.8yrs |
| CEO ownership | 0.8% |
| Management average tenure | 3.6yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
Dec 05
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?
Aug 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
May 05Is Vor Biopharma Inc. (NASDAQ:VOR) Trading At A 49% Discount?
Mar 13We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully
Oct 19Vor Bio appoints Eyal C. Attar as chief medical officer
Oct 12Is Vor Biopharma (NASDAQ:VOR) In A Good Position To Invest In Growth?
Jun 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Mar 05Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Aug 30Vor Biopharma: Targeted Therapies For Transplants
Jun 30We're Not Very Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate
May 10Vor Biopharma EPS misses by $0.03
May 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$606k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$116m |
| Jun 30 2023 | n/a | n/a | -US$106m |
| Mar 31 2023 | n/a | n/a | -US$98m |
| Dec 31 2022 | US$5m | US$570k | -US$92m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$81m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$2m | US$508k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$70m |
| Jun 30 2021 | n/a | n/a | -US$65m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$3m | US$424k | -US$49m |
Compensation vs Market: Robert's total compensation ($USD2.69M) is above average for companies of similar size in the US market ($USD674.55K).
Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.
CEO
Robert Ang (48 yo)
4.8yrs
Tenure
US$2,691,044
Compensation
Dr. Robert Ang, MBBS, MBA, M.D., serves as Independent Non-Executive Director at Enara Bio Limited since September 2021. He is the President, Chief Executive Officer and Director of Vor Biopharma Inc. sinc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.8yrs | US$2.69m | 0.77% $ 925.4k | |
| Chief Scientific Officer | 3.5yrs | US$1.31m | 0.11% $ 127.6k | |
| Chief Medical Officer | 1.6yrs | US$1.40m | 0.014% $ 16.7k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Chief Financial Officer | 4yrs | US$2.17m | 0.13% $ 150.5k | |
| Chief People Officer | 4.4yrs | no data | no data | |
| Chief Commercial Officer | 3.8yrs | no data | no data | |
| Senior Vice President of Portfolio Strategy & Program Management | less than a year | no data | no data | |
| Senior VP & Head of Quality | less than a year | no data | no data |
3.6yrs
Average Tenure
50yo
Average Age
Experienced Management: VOR's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.8yrs | US$2.69m | 0.77% $ 925.4k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.8yrs | US$151.60k | 0% $ 0 | |
| Independent Chairman of the Board | 3.6yrs | US$185.60k | 0.0089% $ 10.6k | |
| Independent Director | 5.3yrs | US$157.50k | 0% $ 0 | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Independent Director | 5.2yrs | US$89.38k | 0.043% $ 51.8k | |
| Independent Director | 3.8yrs | US$164.10k | no data | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Scientific & Clinical Advisor | no data | no data | no data | |
| Scientific & Clinical Advisor | 3.3yrs | no data | no data |
3.8yrs
Average Tenure
52yo
Average Age
Experienced Board: VOR's board of directors are considered experienced (3.8 years average tenure).